American International Group, Inc. Kinnate Biopharma Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$3.46 - $7.98 $972 - $2,242	281 Added 2.03%	14,103 $88,000
Q4 2022 Feb 10, 2023	SELL	$5.26 - $12.19 $263 - $609	-50 Reduced 0.36%	13,822 $84,000
Q3 2022 Nov 14, 2022	BUY	$9.86 - $15.76 $1,922 - $3,073	195 Added 1.43%	13,872 $166,000
Q2 2022 Aug 12, 2022	BUY	$7.43 - $13.0 $6,679 - $11,687	899 Added 7.04%	13,677 $172,000
Q1 2022 May 13, 2022	SELL	$7.73 - $17.99 $6,957 - $16,190	-900 Reduced 6.58%	12,778 $144,000
Q4 2021 Feb 11, 2022	SELL	$16.5 - $25.48 $6,748 - $10,421	-409 Reduced 2.9%	13,678 $242,000
Q3 2021 Nov 12, 2021	BUY	$17.81 - $24.87 $115,569 - $161,381	6,489 Added 85.4%	14,087 $324,000
Q2 2021 Aug 13, 2021	SELL	$22.19 - $31.55 $6,191 - $8,802	-279 Reduced 3.54%	7,598 $177,000
Q1 2021 May 07, 2021	BUY	$26.99 - $40.0 $212,600 - $315,080	7,877 New	7,877 $245,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.